Overall, 36 percent of employers are providing GLP-1 coverage for both diabetes and weight loss (up from 34 percent in 2024)
While GLP-1 therapies improve endothelial function and reduce inflammation, they may also influence heart rate
improves RNA stability and functionality, and its urinary excretion is a possible diagnostic indicator
Thus, it is feasible that even if there may be a tumor-promoting effect that the duration of drug exposure may not be sufficient to significantly increase the risk of tumorigenesis
Grace Liu (PharmD, AFMCP), a functional medicine practitioner with an international integrative medicine practice that includes group classes, private consultations, functional laboratory analysis, and personalized gut protocols
That does not mean GLP-1 medications are bad